ZA200505989B - Use the steroids to treat ocular disorders - Google Patents

Use the steroids to treat ocular disorders

Info

Publication number
ZA200505989B
ZA200505989B ZA200505989A ZA200505989A ZA200505989B ZA 200505989 B ZA200505989 B ZA 200505989B ZA 200505989 A ZA200505989 A ZA 200505989A ZA 200505989 A ZA200505989 A ZA 200505989A ZA 200505989 B ZA200505989 B ZA 200505989B
Authority
ZA
South Africa
Prior art keywords
steroids
ocular disorders
treat ocular
treat
disorders
Prior art date
Application number
ZA200505989A
Other languages
English (en)
Inventor
David P Bingaman
Abbot F Clark
Jani Rajni
Stella M Robertson
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of ZA200505989B publication Critical patent/ZA200505989B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200505989A 2003-02-20 2004-02-04 Use the steroids to treat ocular disorders ZA200505989B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44894303P 2003-02-20 2003-02-20

Publications (1)

Publication Number Publication Date
ZA200505989B true ZA200505989B (en) 2006-12-27

Family

ID=32908674

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200505989A ZA200505989B (en) 2003-02-20 2004-02-04 Use the steroids to treat ocular disorders

Country Status (16)

Country Link
US (2) US20060154910A1 (xx)
EP (1) EP1670480A4 (xx)
JP (1) JP2006518382A (xx)
KR (1) KR20050102652A (xx)
CN (1) CN1750828A (xx)
AR (1) AR043251A1 (xx)
AU (1) AU2004212895A1 (xx)
BR (1) BRPI0407693A (xx)
CA (1) CA2516782A1 (xx)
MX (1) MXPA05008561A (xx)
PL (1) PL378210A1 (xx)
RU (1) RU2005129276A (xx)
TW (1) TW200511996A (xx)
UY (1) UY28202A1 (xx)
WO (1) WO2004073607A2 (xx)
ZA (1) ZA200505989B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2539023A1 (en) * 2003-09-23 2005-04-14 Alcon Inc. Triamcinolone acetonide and anecortave acetate formulations for injection
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
ES2435398T3 (es) * 2004-04-08 2013-12-19 Eye Co Pty Ltd. Tratamiento de retinopatía exudativa con mineralocorticoides
AU2006304416B2 (en) * 2005-10-18 2013-03-28 Allergan, Inc. Ocular therapy using Glucocorticoid Derivatives selectively penetrating posterior segment tissues
US20080076742A1 (en) * 2005-10-31 2008-03-27 Wisconsin Alumni Research Foundation Methods and compositions for treating diseases associated with neovascualrization
ITRM20050547A1 (it) * 2005-11-04 2007-05-05 Sooft Italia S R L Gel oftalmico composto da triamcinolone acetonide e da un polimero poliacrilico.
US8128960B2 (en) 2008-03-11 2012-03-06 Alcon Research, Ltd. Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
TW201105363A (en) 2009-07-14 2011-02-16 Univ Yamagata Eye drop for macular edema treatment
US8957052B2 (en) * 2010-05-10 2015-02-17 Universite Paris Descartes Methods and compositions for the treatment of fluid accumulation in and/or under the retina
KR101106074B1 (ko) * 2011-05-27 2012-01-18 김선미 교통 시설물 설치용 부착대 및 지주장치
US10328048B2 (en) 2014-05-30 2019-06-25 Aarhus Universitet Cafestol for treating diabetes
WO2016144832A1 (en) 2015-03-06 2016-09-15 Envisia Therapeutics, Inc. Implant applicators and methods of administering implants
CN108883070A (zh) 2015-07-23 2018-11-23 爱瑞制药公司 用于治疗眼病的玻璃体内药物递送系统
EP3691654A4 (en) * 2017-09-25 2021-11-24 Surface Pharmaceuticals, Inc. OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5770592A (en) * 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US6172054B1 (en) * 1995-06-15 2001-01-09 Alcon Laboratories, Inc. Combination therapy for lowering and controlling intraocular pressure
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US6011023A (en) * 1997-08-27 2000-01-04 Alcon Laboratories, Inc. Angiostatic steroids
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
DE60016271T2 (de) * 1999-10-21 2005-12-01 Alcon Inc. Medikamentenzuführvorrichtung
US6416777B1 (en) * 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
CA2383572C (en) * 1999-10-21 2007-12-11 Alcon Universal Ltd. Sub-tenon drug delivery
IL146057A (en) * 2000-10-27 2007-09-20 Pfizer Prod Inc A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
US20030023228A1 (en) * 2001-07-20 2003-01-30 Parkinson Thomas M. Ocular iontophoretic device and method for using the same

Also Published As

Publication number Publication date
EP1670480A4 (en) 2007-10-10
WO2004073607A3 (en) 2004-11-25
US20040171598A1 (en) 2004-09-02
TW200511996A (en) 2005-04-01
PL378210A1 (pl) 2006-03-20
MXPA05008561A (es) 2005-11-04
EP1670480A2 (en) 2006-06-21
CN1750828A (zh) 2006-03-22
BRPI0407693A (pt) 2006-03-01
US20060154910A1 (en) 2006-07-13
KR20050102652A (ko) 2005-10-26
UY28202A1 (es) 2004-08-31
RU2005129276A (ru) 2006-01-27
WO2004073607A2 (en) 2004-09-02
CA2516782A1 (en) 2004-09-02
AU2004212895A1 (en) 2004-09-02
JP2006518382A (ja) 2006-08-10
AR043251A1 (es) 2005-07-20

Similar Documents

Publication Publication Date Title
IL175055A0 (en) Combinations useful for the treatment of neuronal disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
HK1092367A1 (en) Combination therapy for the treatment of ocular neovascular disorders
IL173351A0 (en) Therapy of ocular disorders
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
HK1152952A1 (en) Combination therapy for cell disorders
EP1638508A4 (en) SHUNT FOR GLUCKOM TREATMENT
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
IL177490A0 (en) Methods for the treatment of tinnitus induced by cochlear excitotoxicity
IL173909A0 (en) Use of modified cyclosporins for the treatment of hcv disorders
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IL176393A (en) Patterned laser treatment of the retina
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
PL372425A1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
HK1098696A1 (en) Retinal derivatives and methods for the use thereof for the treatment of visual disorders
ME01219B (me) Alfa-aminoamid derivati korisni u liječenju bolesti zavisnosti
PL378108A1 (pl) Leczenie łączone do terapii zapalnych zaburzeń immunologicznych
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
ZA200505989B (en) Use the steroids to treat ocular disorders
GB0523961D0 (en) The treatment of ophthalmic diseases
ZA200405853B (en) Use of adapalene for the treatment of dermatological disorders
EP1613318A4 (en) COMPOUNDS AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISEASES
EP1697536A4 (en) NEW OLIGONUCLEOTIDES AND TREATMENT OF HEART DISEASES USING THEREOF
GB0523964D0 (en) The treatment of ophthalmic diseases
SI1631313T1 (sl) Kombinirana terapija za B-celične motnje